CIK 0000876343 · Non-accelerated filer<br>Smaller reporting company
Lineage Cell Therapeutics, Inc.
Sign in to watch- Ticker
- LCTX
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- operating
- EIN
- 943127919
- Phone
- 5105213390
- Business address
- 2173 SALK AVENUE, SUITE 200, CARLSBAD, CA, 92008
- Former names
- BIOTIME INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-11 | Culley Brian M President and CEO | Option exercise · Restricted Stock Units | −31,249 | 62,499 | ||
| 2024-02-08 | BAILEY DON M Director | Purchase | +96,155 | $1.04 | $100K | 158,801 |
| 2024-02-06 | BROADWOOD PARTNERS, L.P. Director | Purchase | +6,730,770 | $1.04 | $7.0M | 41,666,255 |
| 2024-02-06 | BROADWOOD PARTNERS, L.P. Director | Purchase | +0 | 41,666,255 | ||
| 2023-12-29 | Jayasuriya Anula Director | Purchase | +10,000 | $1.09 | $11K | 10,000 |
| 2023-07-01 | Russell Angus C. Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2023-07-01 | Mulroy Michael H. Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2023-07-01 | KINGSLEY ALFRED D Chairman | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2023-07-01 | Jayasuriya Anula Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2023-07-01 | BAILEY DON M Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2023-07-01 | ANDREWS DEBORAH J Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2023-07-01 | Amin Dipti Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2023-07-01 | BRADSHER NEAL C Director | Grant or award · OPTION TO PURCHASE COMMON SHARES | +50,000 | 50,000 | ||
| 2023-03-09 | Hogge Gary S. SVP,Clinical & Medical Affairs | Grant or award · Employee Stock Option (right to buy) | +400,000 | 400,000 | ||
| 2023-03-09 | Samuel George A. III General Counsel/Secretary | Grant or award · Employee Stock Option (Right to Buy) | +650,000 | 650,000 | ||
| 2023-03-09 | Culley Brian M President and CEO | Grant or award · Employee Stock Option (Right to Buy) | +1,900,000 | 1,900,000 | ||
| 2023-03-09 | Howe Jill Ann Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2023-02-11 | Samuel George A. III General Counsel/Secretary | Option exercise | +6,076 | 6,076 | ||
| 2023-02-11 | Samuel George A. III General Counsel/Secretary | Shares withheld for taxes | −2,478 | $1.35 | $3K | 3,598 |
| 2023-02-11 | Samuel George A. III General Counsel/Secretary | Option exercise · Restricted Stock Units | −6,076 | 18,227 |
Page 4 of 8 · 153 trades